# The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins

> **NCT01341171** · — · COMPLETED · sponsor: **University of Vermont** · enrollment: 30 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01341171
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341171, "The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01341171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
